References
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16(3):178–222.
- Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79–85. doi:10.2188/jea.je20110131.
- McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al.;American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals From the American Heart Association. Circulation 2017;135(17):e927–e999. doi:10.1161/CIR.0000000000000484.
- Parthasarathy P, Agarwal A, Chawla K, Tofighi T, Mondal TK. Upcoming biomarkers for the diagnosis of Kawasaki disease: a review. Clin Biochem. 2015;48(16–17):1188–94. doi:10.1016/j.clinbiochem.2015.02.013.
- van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4(10):620–30. doi:10.1016/S1473-3099(04)01146-6.
- Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263–73. doi:10.3343/alm.2014.34.4.263.
- Okada Y, Minakami H, Tomomasa T, Kato M, Inoue Y, Kozawa K, et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect. 2004;48(2):199–205. doi:10.1016/j.jinf.2003.08.002.
- He XW, Tian J, Yi QJ, Liu XY, Liu TW, Ji XJ, et al. Predictive values of serum proeaicitonin and C reactive protein on coronary artery lesion in children with Kawasaki disease. Chin J Obstet Gynecol Pediatr. 2018;14:31–7.
- Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–90. doi:10.1016/j.jclinepi.2005.02.022.
- Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.
- Wu LQ, Chen JP, He NH. Diagnostic values of procalcitonin, platelet, C-reactive protein, erythrocyte sedimentation rate and white blood cell count for Kawasaki disease. J Third Military Med Univ. 2016;38:2527–31.
- Huang XF. The clinical significance of the Kawasaki disease clinic analysis in a single centre & common laboratory index during the early diagnosis of Kawasaki disease. Fujian: Medical University of Fujian; 2016.
- Zhang Q, Lv Z, Li QL. Evaluation of combined detection of procalcitonin and D-D dimmer et al in the early diagnosis of children with Kawasaki disease. J Clin Exp Med. 2017;16:2060–3.
- Huang JW. The application value of serum PCT, D-D, CRP and BNP in the diagnosis of kawasaki disease in children. Contemporary Med Sympos. 2019;17:163–4.
- Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100(11):1084–8. doi:10.1136/archdischild-2014-307536.
- McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al.; On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation 2017;135(17):927–99. doi:10.1161/CIR.0000000000000484.
- Reitsma JB, Moons KG, Bossuyt PM, Linnet K. Systematic reviews of studies quantifying the accuracy of diagnostic tests and markers. Clin Chem. 2012;58(11):1534–45. doi:10.1373/clinchem.2012.182568.
- Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329(7458):168–9. doi:10.1136/bmj.329.7458.168.
- Liu XP, Huang YS, Kuo HC, Xia HB, Yi-Sun Huang WD, Lang XL, et al. A novel nomogram model for differentiating Kawasaki disease from sepsis. Sci Rep. 2020;10:13745. doi:10.1038/s41598-020-70717-4.
- Hwang B. Epidemiology of Kawasaki disease. Pediatr Neonatol. 2014;55(2):78. doi:10.1016/j.pedneo.2013.10.008.
- Checchia PA, Borensztajn J, Shulman ST. Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol. 2001;22(2):102–6. doi:10.1007/s002460010170.